Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 24, 2014
Pharmacy Choice - News - Over-the-Counter Drugs - July 24, 2014

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 12 of 12     Go To Page:

7/24/14 - Back to the dark ages of medicine ; The government's top doctor says antibitoic resistance is as great a threat as terrorism. Lisa Salmon reports on... [Newcastle Journal (England)]
Back to the dark ages of medicine; The government's top doctor says antibitoic resistance is as great a threat as terrorism. Lisa Salmon reports on the rise of superbugs. It's estimated that drug- resistant strains of bacteria are responsible for 5,000 deaths a year in the UK and 25,000 it's estimated that drug-resistant strains of bacteria are res
7/23/14 - Patent Issued for Dosage Form for Insertion into the Mouth
By a News Reporter-Staff News Editor at Biotech Week A patent by the inventors Ryoo, Je Phil; Chu, Chun Kwong; Wang, Zheng, filed on October 18, 2012, was published online on July 8, 2014, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 8771736 is assigned to NAL Pharmaceuticals, Ltd.. Th
7/23/14 - Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP
Taiho Pharmaceutical Co., Ltd., a fully-fledged oncology pharmaceutical company, announced on July 23 that the company will be investing US $30 million in Remiges BioPharma Fund, a newly formed biotech venture capital fund. At the same time, we recognize the importance of collaborating with academia and biotech ventures outside Japan for efficient
7/22/14 - OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE
OPKO Health, Inc., a multinational biopharmaceutical and diagnostics company, today announced that the United States Patent and Trademark Office granted OPKO a patent covering RAYALDEE?, the Company s product to treat secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency. The new patent
7/21/14 - Allergan Reports Second Quarter 2014 Operating Results
Allergan, Inc. today announced operating results for the quarter ended June 30, 2014. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share, payable on September 5, 2014 to stockholders of record on August 15, 2014. Allergan reported $1.37 diluted earnings per share attributable to stockholder
7/21/14 - Back to the dark ages of medicine ; The government's top doctor says antibitoic resistance is as great a threat as terrorism. Lisa Salmon reports on... [Western Mail (Wales)]
Lisa Salmon reports on the rise of superbugs. It's estimated that drug- resistant strains of bacteria are responsible for 5,000 deaths a year in the UK and 25,000 in Europe. It's estimated that drug-resistant strains of bacteria are responsible for 5,000 deaths a year in the UK and 25,000 in Europe.
7/21/14 - Beware! Don't pop that abortion pill on your own [DNA : Daily News & Analysis (India)]
A research article published in NHL Medical College's in-house journal has thrown up some shocking facts about impacts of self-medication of abortion pills on women's health. The research- based on data collected from 37 women, who had come to VS Hospital for follow-up and treatment after self-medication- found that 89% suffered bleeding from the v
7/21/14 - Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil Congestion Relief Tablets, 200 mg/10 mg
By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg, the store brand equivalent to Advil Congestion Relief Tablet
7/19/14 - FDA OKs NeuroMetrix Wearable Technology for OTC Use in Treatment of Chronic Pain [Professional Services Close - Up]
NeuroMetrix said that its wearable technology for treatment of chronic pain received 510 clearance from the U.S. Food and Drug Administration for over-the-counter use. In its release, NeuroMetrix said that it is in late stage development of a consumer oriented chronic pain treatment product. "Patient response to SENSUS, our prescription wearable d
7/19/14 - Legal but dangerous: Locals work to curb prescription drug abuse [The Evening Sun, Hanover, Pa. :: ]
July 19 Phil Bauer didn't understand the dangers of prescription drug abuse until the day his son didn't wake up. He and his wife found Mark, then only 18, unconscious on his bed just two weeks before his graduation from West York Area High School. It's a story Hanover- Adams prosecutors and medical professionals say they have heard too many time
7/18/14 - "Non-Mucoadhesive Film Dosage Forms" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Leichs, Christian; Breitenbach, Armin; Lehrke, Ingo; Galfetti, Paolo, filed on October 11, 2013, was made available online on July 3, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assi
7/18/14 - Summit Medical, Inc. Receives FDA 510(k) Clearance for Additional Sterilization Cycles
Summit Medical, Inc., striving to maintain their top spot in the medical device industry has achieved yet another goal. They are amongst few in the marketplace to gain FDA clearance for sterilization methods on their state of the art instrument protection trays. We do this to ensure customer confidence in our instrument protection products and to d
Articles(s): 1 - 12 of 12     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415